Godavari Biorefineries Limited
Clinical trials sponsored by Godavari Biorefineries Limited, explained in plain language.
-
Groundbreaking cancer pill enters first human testing
Disease control CompletedThis was the first human trial of a new oral medication called MSP008-22, designed to treat advanced solid tumors like breast, ovarian, and prostate cancer. The study tested single, increasing doses in 7 patients with stage IV cancer to check if the drug was safe and how the body…
Phase: PHASE1 • Sponsor: Godavari Biorefineries Limited • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
First human test for new COVID pill begins
Disease control CompletedThis was the first study in people to test the safety of a new oral drug called MSP008-22, which is being developed to treat COVID-19. It involved 64 healthy adult volunteers who received either the drug or a placebo (a dummy pill) to check for side effects and see how the drug m…
Phase: PHASE1 • Sponsor: Godavari Biorefineries Limited • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC